RegCell
Osaka
About RegCell
RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $51.4M
- Funding stage: Seed
- Last round: Grant (Mar 2025)
- Website: regcellbio.com
Industries & Categories
Alternative Medicine, Clinical Trials, Outpatient Care
Social Profiles
Canonical: https://fsome.com/organization/regcell-6539 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.